Biofrontera Inc BFRI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.07quote price arrow down-0.02 (-1.83%)
Volume
46,583
52 week range
0.61 - 13.42
Loading...
  • Open1.11
  • Day High1.12
  • Day Low1.05
  • Prev Close1.09
  • 52 Week High13.42
  • 52 Week High Date06/20/23
  • 52 Week Low0.61
  • 52 Week Low Date02/08/24

Key Stats

  • Market Cap5.446M
  • Shares Out5.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-61.37

KEY STATS

  • Open1.11
  • Day High1.12
  • Day Low1.05
  • Prev Close1.09
  • 52 Week High13.42
  • 52 Week High Date06/20/23
  • 52 Week Low0.61
  • 52 Week Low Date02/08/24
  • Market Cap5.446M
  • Shares Out5.09M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-61.37

RATIOS/PROFITABILITY

  • EPS (TTM)-15.19
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.35
  • EBITDA (TTM)-20.87M
  • ROE (TTM)-140.43%
  • Revenue (TTM)34.073M
  • Gross Margin (TTM)48.80%
  • Net Margin (TTM)-59.08%
  • Debt To Equity (MRQ)81.45%

EVENTS

  • Earnings Date08/11/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biofrontera Inc

 

Profile

MORE
Biofrontera Inc. is a biopharmaceutical company. The Company is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription...
Hermann Luebbert Ph.D.
Executive Chairman of the Board, Chief Executive Officer
Eugene Frederick Leffler III
Chief Financial Officer
Address
120 Presidential Way,, Suite 330
Woburn, MA
01801
United States

Top Peers

SYMBOLLASTCHG%CHG
RVLPQ
CPIX
Cumberland Pharmaceuticals Inc
1.51+0.01+0.67%
CASI
CASI Pharmaceuticals Inc
3.30+0.05+1.69%
EVOK
Evoke Pharma Inc
0.465-0.0049-1.0428%
TRVN
Trevena Inc
0.4045-0.0025-0.6143%